Evidence map›Paper›PMID 31786580›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

A Single-Nucleotide Polymorphism (rs1131243) of the Transforming Growth Factor Beta Signaling Pathway Contributes to Risk of Acute Rejection in Chinese Renal Transplant Recipients.

Ming Zheng, Haiwei Yang, Wencheng Li, Jiajun Zhou, Jintao Wei, Zijie Wang, Miao Guo, Hao Chen, Li Sun, Zhijian Han and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ming ZhengDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Haiwei YangDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Wencheng LiDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China (mainland).
Jiajun ZhouDepartment of Emergency Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China (mainland).
Jintao WeiDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Zijie WangDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Miao GuoResearch Division of Clinical Pharmacology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Hao ChenDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Li SunDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Zhijian HanDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Jun TaoDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Xiaobing JuDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Ruoyun TanDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Jifu WeiResearch Division of Clinical Pharmacology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Min GuDepartment of Urology, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China (mainland).
Nanjing Medical University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Acute rejection (AR) is a common complication of kidney transplantation. The transforming growth factor beta (TGF-ß) signaling pathway has been observed to be involved in several cellular functions. Our study aimed to investigate the correlations between single-nucleotide polymorphisms (SNPs) in TGF-ß-related genes and the risk of AR in renal transplant recipients. MATERIAL AND METHODS This retrospective, single-center study included 200 Chinese renal transplant recipients. All exons, exon/intron boundaries, and flanking regions of the TGF-ß signaling pathway were detected by targeting sequencing (TS) based on next-generation sequencing technology. Tagger SNPs and haplotypes were identified after adjustment. A general linear model (GLM) was used to explore the confounding effect of clinical variables. Five adjusted inheritance models were utilized to investigate the influence of SNPs on AR, and Banff score was applied to evaluate the effect of related SNPs on pathological changes. RESULTS A total of 188 SNPs on TGF-ß genes were detected. Analysis of adjustment led to identification of 31 tagger SNPs and 10 haplotype blocks. After the analysis of a general linear model and 5 sirolimus-adjusted multiple inheritance models, 1 of the SNPs - rs1131243 on the TGF-ßR3 gene - was observed to be significantly associated with the occurrence of AR. Based on Banff score, no significant association was observed between SNPs and pathological changes. CONCLUSIONS In this study, we observed that the SNP rs1131243 on the TGF-ßR3 gene was significantly associated with the occurrence of AR in Chinese renal transplant recipients.

Indexed as

Graft RejectionTransforming Growth Factor betaAdultAsian PeopleChinaFemaleGenotypeHaplotypesHumansKidneyKidney TransplantationMaleMiddle AgedPolymorphism, Single NucleotideRetrospective StudiesRisk FactorsTransforming Growth Factor beta

Identifiers

PMID31786580
PMCPMC6910173
OpenAlexW2991689997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.